Epilepszia: vizsgálatok itt: Ausztrália

In Ausztrália 22 Also abroad 452

22 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Where
Heidelberg, Melbourne, Nedlands, South Brisbane
Életkor
4 év to 55 év
People
252 worldwide
Run by
SK Life Science, Inc.
See details and how to joinNCT05219617
3. fázisTaking people
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Where
Melbourne, Sydney
Életkor
18 év to 75 év
People
333 worldwide
Run by
Rapport Therapeutics Inc.
See details and how to joinNCT07563881
3. fázisTaking people
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Where
Melbourne
Életkor
18 év to 75 év
People
312 worldwide
Run by
Rapport Therapeutics Inc.
See details and how to joinNCT07594119
3. fázisTaking people
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Where
Heidelberg, Kogarah, Melbourne, Parkville, South Brisbane
Életkor
12 év and over
People
160 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00
3. fázisTaking people
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Where
Camperdown, Melbourne, Randwick, Westmead
Életkor
18 év and over
People
360 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00
3. fázisCsak meghívásos
An Open-label Study of XEN1101 in Epilepsy
Where
Camperdown, Fitzroy, Heidelberg, Kogarah, Melbourne, Parkville, Randwick, South Brisbane, Westmead
Életkor
12 év and over
People
880 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00
2. fázisCsak meghívásos
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Where
Melbourne
Életkor
18 év and over
People
100 worldwide
Run by
Supernus Pharmaceuticals, Inc.
See details and how to joinNCT07141329 · EU 2026-526361-15-00
1/2. fázisTaking people
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Where
Melbourne
Életkor
6 hónap to 17 év
People
113 worldwide
Run by
Encoded Therapeutics
See details and how to joinNCT05419492
No phaseTaking people
Artificial Intelligence for Brain MRI Analysis in Epilepsy
Where
Melbourne
People
2000 worldwide
Run by
Istituto Giannina Gaslini
See details and how to joinNCT07881185
3. fázisCsak meghívásos
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Where
Brisbane, Heidelberg, Parkville, Randwick, Westmead
Életkor
2 év to 66 év
People
324 worldwide
Run by
Longboard Pharmaceuticals
See details and how to joinNCT06908226 · EU 2024-514974-39-00
2. fázisTaking people
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Where
Adelaide, Clayton, Fitzroy, Herston, Melbourne, Nedlands, Parkville
Életkor
18 év to 70 év
People
216 worldwide
Run by
Supernus Pharmaceuticals, Inc.
See details and how to joinNCT06798896
2. fázisTaking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of CB03-154 in Adult Patients With Focal Epilepsy
Where
Melbourne
Életkor
18 év to 70 év
People
180
Run by
Shanghai Zhimeng Biopharma, Inc.
See details and how to joinNCT06612775
No phaseTaking people
Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy
Where
Clayton, Fitzroy, Heidelberg, Herston, Melbourne, Parkville, South Brisbane
Életkor
4 év to 75 év
People
30
Run by
iVEAcare
See details and how to joinNCT07640191
No phaseTaking people
Prospective Natural History Study of POLG Disease
Where
Sydney
People
300 worldwide
Run by
The POLG Foundation
See details and how to joinNCT07775872
No phaseTaking people
Evaluation of the NaviFUS System in Drug Resistant Epilepsy
Where
Melbourne
Életkor
18 év and over
People
18
Run by
Genovate-NaviFUS (Australia) Pty Ltd.
See details and how to joinNCT05947656
No phaseNot yet taking people in Ausztrália
IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).
Where
Perth
Életkor
0 év to 15 év
People
40 worldwide
Run by
Telethon Kids Institute
See details and how to joinNCT07585643
No phaseCsak meghívásos
5-SENSE Score Validation Study
Where
Brisbane, Melbourne
Életkor
15 év and over
People
400 worldwide
Run by
Duke University
See details and how to joinNCT06138808
2. fázisCsak meghívásos
Long-term Safety and Tolerability of BHV-7000
Where
Bedford Park, Camperdown, Fitzroy, Heidelberg, Herston, Melbourne, Parkville, Randwick
Életkor
18 év to 75 év
People
660 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00
2. fázisTaking people
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Where
Box Hill, Brisbane, Heidelberg, Melbourne, Parkville, Randwick, Sydney
Életkor
18 év to 70 év
People
60 worldwide
Run by
Supernus Pharmaceuticals, Inc.
See details and how to joinNCT05518578
2. fázisTaking people
An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in Subjects Diagnosed With Epilepsy
Where
Melbourne
Életkor
18 év to 70 év
People
144
Run by
Shanghai Zhimeng Biopharma, Inc.
See details and how to joinNCT07238868
2. fázisTaking people
BMB-101 in Absence Epilepsy and DEE
Where
Fitzroy, Heidelberg, Herston, Melbourne, Randwick
Életkor
18 év to 65 év
People
20
Run by
Bright Minds Biosciences Pty Ltd
See details and how to joinNCT06401538
2. fázisTaking people
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Where
Heidelberg, Melbourne
Életkor
18 év to 75 év
People
50 worldwide
Run by
Praxis Precision Medicines
See details and how to joinNCT06908356